XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Cash flows from operating activities    
Net loss $ (34,750,000) $ (26,914,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4,283,000 2,044,000
Amortization of deferred sales commissions 4,631,000 3,401,000
Amortization (accretion) of marketable securities purchased at a premium (discount) 790,000 566,000
Stock-based compensation, net of amounts capitalized 13,277,000 12,133,000
Non-cash operating lease cost 1,055,000 1,062,000
Other (162,000) 23,000
Changes in operating assets and liabilities    
Accounts receivable 757,000 837,000
Prepaid expenses (37,000) 592,000
Other assets 180,000 1,144,000
Deferred sales commissions (3,934,000) (5,658,000)
Accounts payable 2,181,000 1,383,000
Accrued expenses and other current liabilities (164,000) (1,295,000)
Deferred revenue 11,451,000 9,177,000
Operating lease liabilities (1,156,000) (1,134,000)
Other liabilities 166,000 (80,000)
Net cash used in operating activities (1,432,000) (2,719,000)
Cash flows from investing activities    
Purchases of marketable securities (51,683,000) (267,548,000)
Maturities of marketable securities 41,022,000 1,558,000
Sales of marketable securities 5,920,000 0
Purchases of property and equipment (371,000) (247,000)
Capitalized internal-use software costs (187,000) 0
Net cash used in investing activities (5,299,000) (266,237,000)
Cash flows from financing activities    
Payments of deferred offering costs 0 (93,000)
Proceeds from exercise of common stock options 6,954,000 8,019,000
Net cash provided by financing activities 6,954,000 7,926,000
Effect of exchange rate changes on cash and cash equivalents (472,000) (9,000)
Change in cash and cash equivalents and restricted cash (249,000) (261,039,000)
Beginning of period 80,286,000 404,440,000
End of period 80,037,000 143,401,000
Supplemental disclosures of cash flow information    
Cash paid for income taxes 728,000 272,000
Cash paid for interest 21,000 21,000
Supplemental non-cash investing and financing information    
Vesting of early exercised options 31,000 49,000
Unpaid cash consideration for acquisitions 456,000 0
Stock-based compensation capitalized as internal-use software costs 51,000 0
Property and equipment accrued but not yet paid 0 575,000
Reconciliation of cash, cash equivalents, and restricted cash to consolidated balance sheets    
Cash and cash equivalents 79,737,000 143,101,000
Restricted cash included in other current assets 300,000 300,000
Total cash, cash equivalents, and restricted cash $ 80,037,000 $ 143,401,000